The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials
2.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
3.
Are patients with advanced cancer receiving treatment aligned with their goals?
4.
PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.
5.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
1.
Red Cell Adaptation During Female Reproductive Transitions: Mechanisms, Clinical Implications, and Evidence-Based Insights
2.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
3.
Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology
4.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
5.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part I
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation